Last updated on July 2018

Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin


Brief description of study

Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin

Detailed Study Description

Type 2 Diabetes? Currently using Insulin? Such as Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin

You may be eligible to participate in a 58 week Research Study if you are:

  • Diagnosed with Type 2 Diabetes
  • Currently using insulin
  • Age 18 or older

ClinicalTrials.gov Identifier: NCT03078478

Clinical Study Identifier: TX148023

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.